SAGE Open Medicine | |
Risk of new-onset diabetes associated with statin use: | |
Robert DBeckett1  | |
关键词: HMG-CoA reductase inhibitors; new-onset diabetes; drug-induced diseases; | |
DOI : 10.1177/2050312115605518 | |
学科分类:医学(综合) | |
来源: Sage Journals | |
【 摘 要 】
Objective:To identify and assess studies investigating the association between statins and new-onset diabetes and determine the clinical significance of this risk.Data sources:A MEDLINE (1977–April 2015), Google Scholar (1997–April 2015), and International Pharmaceutical Abstracts (1977–April 2015) search was performed using the search terms hydroxymethylglutaryl-CoA reductase inhibitors, hydroxymethylglutaryl-CoA reductase inhibitors/adverse effects, statins, adverse effects, diabetes mellitus, diabetes mellitus/etiology, and drug-induced. Citations of identified articles and clinical practice guidelines were also reviewed.Study selection and data extraction:Articles describing results from original investigations or meta-analyses specifically designed to assess the association between statins and new-onset diabetes and published in English were included.Data synthesis:A total of 13 cohort studies and seven meta-analyses were included. In all, 11 were retrospective cohort studies and reported some degree...
【 授权许可】
CC BY
【 预 览 】
Files | Size | Format | View |
---|---|---|---|
RO201904029659044ZK.pdf | 100KB | download |